LAMIVUDINE and ZIDOVUDINE

Product NDC

50090-3920

11-digit product format

500903920

Labeler code

50090

Product ID

50090-3920_005efbaa-2707-410c-a925-faf06153b2ea

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

LAMIVUDINE and ZIDOVUDINE

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

A-S Medication Solutions

Application

ANDA079124

Marketing category

ANDA

Marketing start

2015-09-18

Marketing end

0000-00-00

Substance

LAMIVUDINE; ZIDOVUDINE

Active strength

150 mg/1; mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2019-12-31

Current FDA listing

Historical FDA.report record